FOR YOUR PATIENTS
Explaining Percepta GSC test to patients
In the event a bronchoscopy doesn’t show a conclusive result, you can order the Percepta Genomic Sequencing Classifier (GSC) test. Percepta GSC uses RNA whole-transcriptome sequencing with machine learning, to stratify the risk of primary lung cancer to guide patient management.
Help your qualified patients
At the start of the bronchoscopy procedure, collect samples from the airway using a small brush and send samples to Veracyte.
Smoking can cause lasting changes to the genes inside the cells in your airway.
The Percepta GSC test looks for and analyzes these genomic changes.
The Percepta GSC results stratify the risk of primary lung cancer to guide patient management.
This handout may help healthcare professionals discuss the Percepta Genomic Sequencing Classifier with patients and how the test works.
Billing and reimbursement
Covered by Medicare
The Percepta GSC test is covered by Medicare. Veracyte bills Medicare and third-party payers directly.
The Veracyte Access Program provides financial support for both eligible uninsured and commercially available insured patients with financial need.